A Study of Inlexisertib (DCC-3116) in Combination With Anticancer Therapies in Participants With Advanced Malignancies
Deciphera Pharmaceuticals, LLC
Deciphera Pharmaceuticals, LLC
Bayer
AstraZeneca
Kura Oncology, Inc.
GlaxoSmithKline
IDRx Inc. - A GSK Company
Novelty Nobility, Inc.
Travera Inc
Ascentage Pharma Group Inc.